+4 9 (0) 60 7 4 487 6 0
standing the test of time

Coxiella burnetii (Q-Fever)

The pathogen Coxiella burnetii is a gramnegative bacterium and belongs to the family Rickettsiaceae. It is the causative agent of Q-Fever, an acute rickettsial disease.  

It can be considered the most infectious disease in the world, as a human being can be infected by a single bacterium. It can be found worldwide, including tropical countries, with the exception of New Zealand. In Europe it appears as hepatitis rather than pneumonia as in the United States.

The most common manifestation is flu-like symptoms. The fever lasts approximately 7 to 14 days. The disease can progress to an atypical pneumonia, which can result in a life threatening acute respiratory distress syndrome (ARDS). Occasionally, Q fever causes hepatitis, which may be asymptomatic or becomes symptomatic with malaise, fever, liver enlargement and pain in the right upper quadrant of the abdomen.

The chronic form of Q fever is very similar to inflammation of the inner lining of the heart, which can occur months or decades following the infection. It is fatal if left untreated, however with the correct treatment the mortality rate falls under 10%.

Species

Disease

Symptoms

Mechanism of Infection

Coxiella burnetii

Acute Q Fever:

Self-limited illness, Pneumonia, Hepatitis

Chonic Q Fever

Flu like symptoms with abrupt onset of fever, profuse perspiration, severe headache, muscle pain, loss of appetite, chills

Q-fever endocarditis

It can be found in both humans and animals

Results from inhalation of contaminated aerosols and from contact with urine, feces or milk from infected animals

Incubation period: 9 to 40 hours

 

Acute & Chronic Q-fever Infections:

  • Acute Infection: IgM and IgG antibodies to phase 2 antigen present
    • Tests available: COX2G0600 and COX2M0600
  • Chronic Infection: IgG and IgA antibodies to phase 1 antigen persent
    • Tests available: COX1G0600

 

Infections may be diagnosed by:

  • PCR:    Molecular detection of bacterial DNA is increasingly used
  • Serology:    Determination of specific antibodies based on the ELISA-technique

 

NovaLisa? Coxiella burnetii IgG/IgM ELISA:

The NovaLisa? Coxiella burnetii IgG/IgM ELISA is intended for the qualitative determination of IgG- and IgM- class antibodies against Coxiella burnetii in serum or plasma.

Antigens:

IgG and IgM Coxiella burnetii IgG antigens

Specific performance characteristics:

Intraassay

Interassay

Sensitiviti %

Specificity %

n

Mean (OD)

CV%

n

Mean (NTU)

CV%

Phase 1 IgG

Low+

15

0,57

5,7

5 (2)

9,62

2,4

88

>90

High+

15

1,5

4,7

6 (2)

27,4

3,5

Phase 2 IgG

Low+

15

0,42

3,4

5 (2)

10,1

10,8

>90

>90

High+

16

0,78

2,6

6 (2)

19,5

1,7

Phase 2 IgM

Low+

15

0,38

2,9

6 (2)

16,8

7,7

>90

>90

High+

15

0,72

2

6 (2)

19,2

2,4

 

Order information:

ELISA

Number of Determinations

Product Number

Coxiella burnetii Phase 1 IgG

96

COX1G0600

Coxiella burnetii Phase 2 IgG

96

COX2G0600

Coxiella burnetii Phase 2 IgM

96

COX2M0600